MS

Mousomi Samanta

Active Director Director DIN 10114467
DIN 10114467 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Mousomi Samanta

Data last updated:

Mousomi Samanta is a Director at Pharmasky Healthcare Private Limited (since 2023). Pharmasky Healthcare Private Limited reported revenue of ₹5.2 Lakh (FY 2024).

DIN 10114467
Primary Designation Director
First Appointment 12 Apr 2023
Oldest Company Age 3 yrs
Largest company Pharmasky Healthcare Private Limited · ₹5.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmasky Healthcare Private Limited U46497UP2023PTC180038
Director12 Apr 20232023₹5.2 Lakh (FY 2024)Active

Board colleagues of Mousomi Samanta

NameDINCompanyDesignation
Kaushik Samanta10114468Pharmasky Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmasky Healthcare Private Limited
Premium access

Shareholding and investment profile for Mousomi Samanta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mousomi Samanta

Mousomi Samanta currently holds 1 directorship: Pharmasky Healthcare Private Limited (Director, since 12 Apr 2023, revenue ₹5.2 Lakh (FY 2024)).

Mousomi Samanta was first appointed on 12 Apr 2023 as Director at Pharmasky Healthcare Private Limited.

The current boards of Mousomi Samanta's companies include Kaushik Samanta (Pharmasky Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available